Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
NewcelX Ltd. (NCEL)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 14, 2026 | CORRESP | Neutral/Informational | Moderate | NewcelX Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement No. 333-295770 on Form F-3. The company aims for the regist… | Read Filing EDGAR |
| May. 14, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to NewcelX Ltd. that it will not review the company's registration statement filed on May 11, 2026. The letter emphasizes that the responsibility for the … | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Moderate | NLS Pharmaceutics Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement No. 333-290516 on Form F-1. They aim for the st… | Read Filing EDGAR |
| Sep. 29, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to NLS Pharmaceutics Ltd. that they will not review the company's registration statement filed on September 25, 2025. This decision emphasizes that the re… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.